Cancer stem cells in solid tumors: elusive or illusive?
During the past years in vivo transplantation experiments and in vitro colony-forming assays indicated that tumors arise only from rare cells. These cells were shown to bear self-renewal capacities and the ability to recapitulate all cell types within an individual tumor. Due to their phenotypic resemblance to normal stem cells, the term "cancer stem cells" is used. However, some pieces of the puzzle are missing: (a) a stringent definition of cancer stem cells in solid tumors (b) specific markers that only target cells that meet the criteria for a cancer stem cell in a certain type of tumor. These missing parts started an ongoing debate about which is the best method to identify and characterize cancer stem cells, or even if their mere existence is just an artifact caused by the experimental procedures. Recent findings query the cancer stem cell hypothesis for solid tumors itself since it was shown in xenograft transplantation experiments that under appropriate conditions tumor-initiating cells are not rare.In this review we critically discuss the challenges and prospects of the currently used major methods to identify cancer stem cells. Further on, we reflect the present discussion about the existence of cancer stem cells in solid tumors as well as the amount and characteristics of tumor-initiating cells and finally provide new perspectives like the correlation of cancer stem cells and induced pluripotent cells.
Welte
Yvonne
Y
Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Ihnestrasse 63-73, 14195 Berlin, Germany. regenbre@molgen.mpg.de.
Adjaye
James
J
Lehrach
Hans R
HR
Regenbrecht
Christian Ra
CR
Front Biosci. 2006 Jan 01;11:733-42
16146765
PLoS One. 2008;3(10):e3469
18941626
Blood. 2002 Jan 15;99(2):507-12
11781231
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11154-9
16849428
Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12339-44
12218177
J Int Med Res. 2009 Mar-Apr;37(2):503-10
19383245
Eur J Cancer. 2007 Mar;43(5):935-46
17320377
Cancer Res. 2007 Apr 15;67(8):3691-7
17440081
Nature. 2008 Dec 4;456(7222):593-8
19052619
Nat Biotechnol. 2008 Aug;26(8):916-24
18594521
Cancer Res. 2006 Feb 15;66(4):1891-5; discussion 1890
16488984
Br J Cancer. 2003 Oct 20;89(8):1581-9
14562035
Science. 1977 Jul 29;197(4302):461-3
560061
Pharmazie. 2009 May;64(5):296-300
19530439
Exp Hematol. 2002 Nov;30(11):1339-45
12423688
J Pathol. 2008 Apr;214(5):564-73
18266310
Cell. 1994 May 20;77(4):491-502
7910522
Cancer Res. 2007 Jun 15;67(12):5727-36
17575139
J Invest Dermatol. 2006 Jan;126(1):142-53
16417230
Nature. 2001 May 17;411(6835):349-54
11357142
J Biol Chem. 2000 Feb 25;275(8):5512-20
10681530
Nat Med. 2001 Sep;7(9):1028-34
11533706
Cell. 2006 Aug 25;126(4):663-76
16904174
Cell Tissue Res. 2005 Jan;319(1):15-26
15558321
Gastroenterology. 2005 Nov;129(5):1567-80
16285956
Nat Cell Biol. 2001 Sep;3(9):778-84
11533656
Cancer Sci. 2009 Jun;100(6):1040-6
19385971
Mod Pathol. 2007 Jan;20(1):102-7
17143262
J Clin Invest. 2000 Jul;106(1):3-8
10880041
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16281-6
19805294
Nature. 2007 Jan 4;445(7123):111-5
17122771
Nat Med. 2009 Sep;15(9):1010-2
19734877
Br J Haematol. 2001 Oct;115(1):186-94
11722432
Science. 1992 Mar 27;255(5052):1707-10
1553558
Stem Cell Rev. 2008 Dec;4(4):319-28
18561035
Br J Cancer. 1973 Aug;28(2):123-35
4730176
Invest Ophthalmol Vis Sci. 2003 Jun;44(6):2764-73
12766085
Science. 2007 Jul 20;317(5836):337
17641192
Cancer Res. 2005 Jul 15;65(14):6207-19
16024622
Cell. 1991 Jul 12;66(1):85-94
1712673
Cell. 1998 Nov 25;95(5):605-14
9845363
J Photochem Photobiol B. 2003 May-Jun;70(2):107-15
12849701
Ann N Y Acad Sci. 2009 Sep;1176:154-69
19796244
Nature. 2004 Nov 18;432(7015):396-401
15549107
Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):8912-7
19447925
Nature. 2003 May 15;423(6937):255-60
12714970
J Exp Med. 1996 Apr 1;183(4):1797-806
8666936
Exp Cell Res. 2006 Nov 15;312(19):3701-10
17046749
FEBS Lett. 2007 Apr 3;581(7):1435-40
17362939
Endocrinology. 2007 Apr;148(4):1797-803
17234707
Cancer Res. 1986 Jul;46(7):3556-9
3708586
Nature. 2008 Jan 17;451(7176):345-9
18202660
Cancer Res. 2008 Oct 1;68(19):7882-6
18829544
Clin Chim Acta. 2004 May;343(1-2):173-8
15115691
Cell Biol Int. 2009 Aug;33(8):807-15
19477285
Histopathology. 2009 Sep;55(3):284-93
19723143
Cancer Cell. 2005 Jan;7(1):17-23
15652746
Endocrinology. 2008 Mar;149(3):1314-22
18063677
Nat Genet. 1998 Aug;19(4):379-83
9697701
Cancer Res. 2005 Oct 15;65(20):9328-37
16230395
Semin Cancer Biol. 2005 Oct;15(5):378-86
15975825
Acta Unio Int Contra Cancrum. 1959;15(Suppl 1):196-8
14420161
Neoplasma. 2009;56(5):371-8
19580337
J Natl Cancer Inst. 1971 Feb;46(2):411-22
5115909
Methods Mol Biol. 2009;568:139-49
19582424
Stem Cells. 2006 Mar;24(3):506-13
16239320
J Clin Invest. 1977 Oct;60(4):846-54
302265
Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14228-33
15381773
Nat Biotechnol. 2008 Jul;26(7):795-7
18568017
Hepatology. 2006 Jul;44(1):240-51
16799977
Cancer Lett. 2010 May 28;291(2):150-7
19913993
Ann Surg Oncol. 2008 Feb;15(2):638-48
17932721
Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):781-6
14711994
Nature. 2001 Nov 1;414(6859):105-11
11689955
Cancer Res. 2007 Apr 15;67(8):3716-24
17440084
Cancer Lett. 2008 Sep 8;268(1):1-9
18487012
Int J Clin Pract. 2008 Aug;62(8):1212-8
18479363
In Vitro Cell Dev Biol Anim. 2008 Jul-Aug;44(7):280-9
18594936
Int J Cancer. 2008 Feb 15;122(4):761-8
17955491
Cell Cycle. 2005 Feb;4(2):203-5
15655356
Nature. 2005 Apr 14;434(7035):843-50
15829953
Clin Transl Oncol. 2009 Jul;11(7):411-27
19574199
Pigment Cell Melanoma Res. 2010 Feb;23(1):41-56
19843243
Mol Cancer. 2006 Dec 02;5:67
17140455
Sci China C Life Sci. 2009 Jul;52(7):622-36
19641867
J Clin Invest. 2008 Jun;118(6):2111-20
18497886
J Hematother Stem Cell Res. 2001 Apr;10(2):273-81
11359674
Nature. 2008 Jul 3;454(7200):49-55
18509334
Stem Cells. 2008 Dec;26(12):3008-17
18802032
Biochem Biophys Res Commun. 2008 Apr 18;368(4):930-6
18279661
Exp Cell Res. 2004 Aug 1;298(1):144-54
15242769
Toxicol In Vitro. 2010 Mar;24(2):538-45
19913610